Daniel W. Muehl, See Remarks at Clovis Oncology, Inc. (CLVS), sold 4,570 shares at $1.97 ($9K) on 2022-05-02, disclosed to the SEC on 2022-05-03.
Seasonal sale ($9k) by See Remarks — this insider has traded CLVS in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.97 | 2,062 | $4K | 45.1% |
| 2 | $1.97 | 2,508 | $5K | 54.9% |
| Total | $1.97 avg | 4,570 | $9K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-03-03 | $20K | — | Filing → |